The results showed that only the expression level of CRTC2 in ovarian cancer was negatively correlated with the overall survival of patients [HR=1.54 (1.25-1.89), p < 0.001] (Figure 2B-D). The gene discussed is CRTC2; the disease is ovarian carcinoma.